See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Natural Disasters
Social Media
Donald Trump
Republican Party
Baseball
South America
Senate
Basketball
Democratic Party
Vladimir Putin
Artificial Intelligence
Crime
Published • loading... • Updated

USA approves Astrazeneca-Daiichi therapy for HER2 breast cancer

Summary by redaccionmedica.com
AstraZeneca therapy has been approved in the United States for the treatment of adult patients with non-resectable or metastatic breast cancer with hormone-positive receptors (RH), HER2-low (IHC 1+ or IHC 2+/ISH-) or HER2-ultralow (IHC 0 with membrane staining), as determined by a test validated by the U.S. Food and Drug Administration (FDA), whose disease has progressed after one or more endocrine therapies in the metastatic context.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
hna.dehna.de

Woman researches breast cancer, then she falls ill herself – certain skin changes made her stutzig

A doctoral cancer researcher received an unexpected diagnosis: breast cancer. The expert would have liked to know one thing earlier.

Read Full Article
redaccionmedica.comredaccionmedica.com

USA approves Astrazeneca-Daiichi therapy for HER2 breast cancer

AstraZeneca therapy has been approved in the United States for the treatment of adult patients with non-resectable or metastatic breast cancer with hormone-positive receptors (RH), HER2-low (IHC 1+ or IHC 2+/ISH-) or HER2-ultralow (IHC 0 with membrane staining), as determined by a test validated by the U.S. Food and Drug Administration (FDA), whose disease has progressed after one or more endocrine therapies in the metastatic context.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

redaccionmedica.com broke the news in on Friday, February 14, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Breast Cancer

Breast Cancer

AstraZeneca

AstraZeneca

United States

United States

Germany

Germany

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
Search
BlindspotLocal